These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1792782)

  • 21. [The current concepts of the mechanisms of the therapeutic-prophylactic action of probiotics from bacteria in the genus Bacillus].
    Smirnov VV; Reznik SR; V'iunitskaia VA; Sorokulova IB; Samgorodskaia NV; Tofan AV
    Mikrobiol Z; 1993; 55(4):92-112. PubMed ID: 8220833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Etiology of acute enteric infection in children with arid zone and effect of probiotics].
    Utemuradova GE
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):98-100. PubMed ID: 19623719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotic sensitivity of bifidobacteria and lactobacteria used in the preparation of bifidobacterin and lactobacterin].
    Grigor'eva VM; Astanina LN; Lesniak SV; Evtukhova LN
    Antibiotiki; 1983 Jun; 28(6):418-21. PubMed ID: 6881951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bificol in the complex treatment of patients with infectious diseases].
    Markova EA; Dvurechenskaia GS; Pospelova VV; Rakhimova NG
    Ter Arkh; 1979; 51(2):99-101. PubMed ID: 371053
    [No Abstract]   [Full Text] [Related]  

  • 25. [Outlook for using bacteria of the genus Bacillus for the design of new biopreparations].
    Sorokulova IB
    Antibiot Khimioter; 1996; 41(10):13-5. PubMed ID: 9027285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
    Kushnareva MV; Keshishian ES; Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intestinal dysbacteriosis: current aspects of studying the problem, principles of diagnosis and treatment].
    Ardatskaia MD; Dubinin AV; Minushkin ON
    Ter Arkh; 2001; 73(2):67-72. PubMed ID: 11338863
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of dry bifidumbacterin in the complex treatment of chronic inflammatory diseases of the large intestine].
    Iukhvidov ZhM; Semenova LP; Kuznetsov GG; Grigor'eva GA; Goncharova GP
    Sov Med; 1977 Feb; (2):104-9. PubMed ID: 854769
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of acipole in prevention of enteric dysbacteriosis due to antibacterial therapy].
    Oleĭnichenko EV; Mitrokhin SD; Nonikov VE; Minaev VI
    Antibiot Khimioter; 1999; 44(1):23-5. PubMed ID: 10095921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The policy on treating patients with generalized acute intestinal infections].
    Pokrovskiĭ VI; Iushchuk ND; Tumanov FA
    Ter Arkh; 1989; 61(1):116-20. PubMed ID: 2718104
    [No Abstract]   [Full Text] [Related]  

  • 31. [Correction of intestinal dysbacteriosis in elderly patients with the use of bifidobacterin introduced by different routes].
    Chulok TA; Kaverina KG; Shumova SL; Matsulevich TV; Doroshenko EO
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):76-8. PubMed ID: 15188566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Pobedinskaia IN; Gevondian VS; Gevondian NM; Mitrokhin SD; Minaev VI; Dzis NB; Makkaveeva LF; Kovalev IV; Murashova AO; Bondarenko VM
    Antibiot Khimioter; 2000; 45(10):22-7. PubMed ID: 11212396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Composition and use of bacterial cultures for therapeutic purposes].
    Reuter G
    Arzneimittelforschung; 1969 Jan; 19(1):103-9. PubMed ID: 4978159
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prospects for using bacteriocins for the prevention and therapy of infections].
    Blinova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):10-4. PubMed ID: 6377774
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dysbacteriosis of the intestine in persons exposed to tetracycline under conditions of production and their treatment with colibacterin].
    Vil'shanskaia FL; Shteĭnberg GB; Kats IZ; Pospelova VV; Krylova NF
    Antibiotiki; 1969 Nov; 14(11):1043-6. PubMed ID: 4907800
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pseudomembranous colitis and "intestinal sepsis" as a consequence of dysbacteriosis due to antibiotics].
    Eriukhin IA; Shliapnikov SA; Lebedev VF; Ivanov GA
    Vestn Khir Im I I Grek; 1997; 156(2):108-11. PubMed ID: 9235747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dysbacteriosis: modern conceptions. Diagnosis. Possible management].
    Mitrokhin SD
    Antibiot Khimioter; 2004; 49(7):22-33. PubMed ID: 15690911
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunoglobulin and lysozyme content in the intestines during correction of the dysbacteriosis of acute leukemia patients].
    Martynova VA; Tolkacheva TV; Abakumov EM; Golosova TV
    Vopr Onkol; 1981; 27(7):39-43. PubMed ID: 6943866
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of biological preparations in intestinal diseases].
    Vil'shanskaia FL; Pospelova VV; Rakhimova NG
    Med Sestra; 1976 Jul; 35(7):17-9. PubMed ID: 1050579
    [No Abstract]   [Full Text] [Related]  

  • 40. [The correction of dysbiotic disorders of the vaginal microflora by using a preparation made from highly adhesive lactobacteria].
    Korshunov VM; Kafarskaia LI; Volodin NN; Tarabrina NP
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jul; (7):17-9. PubMed ID: 2251884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.